Clinical Trial Update: Value of F-18 FDG PET/CT for the Prediction of EGFR Mutation in Lung Cancer Patients

View source ↗

Summary

This clinical trial investigates whether F-18 FDG PET/CT can predict EGFR mutation status in lung cancer patients and is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Assiut University | Conditions: Lung Cancer | Status: NOT_YET_RECRUITING